Global Polymyxin B Sulfate API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Polymyxin B Sulfate API market size was valued at US$ 198 million in 2024 and is forecast to a readjusted size of USD 298 million by 2031 with a CAGR of 6.0% during review period.
Polymyxin B Sulfate Active Pharmaceutical Ingredient (API) refers to the active pharmaceutical ingredient used to produce polymyxin B sulfate preparations and is the core active substance in the preparation. Its chemical name is polymyxin B sulfate, which belongs to the polypeptide antibiotics. It is prepared by fermentation process or chemical synthesis and is ultimately used to prepare injections, powder injections and other dosage forms. Polymyxin B sulfate API is the basic substance for the production of drugs against multidrug-resistant Gram-negative bacteria, and its quality directly affects the safety and effectiveness of the preparation. Through strict process control and quality standards, its reliable application as a "last line of defense" antibiotic in clinical practice can be ensured.
The global increase in the infection rate of carbapenem-resistant Gram-negative bacteria (CRO), such as carbapenem-resistant Klebsiella pneumoniae (CRKP) and Pseudomonas aeruginosa (CRPA), has driven the demand for polymyxin B as a "last line of defense" antibiotic. The WHO lists polymyxins as core drugs for the treatment of multidrug-resistant bacterial infections, and the US IDSA guidelines also recommend their use in combination therapy. In addition, due to the abuse of antibiotics and differences in medical levels, the Asia-Pacific and Latin American regions have prominent problems with drug-resistant bacteria, making them the main regions for the growth of demand for polymyxin B sulfate API.
This report is a detailed and comprehensive analysis for global Polymyxin B Sulfate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Polymyxin B Sulfate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Polymyxin B Sulfate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Polymyxin B Sulfate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Polymyxin B Sulfate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Polymyxin B Sulfate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Polymyxin B Sulfate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xellia Pharmaceuticals Aps, Biotika As, Medisca, Hangzhou Zhongmei Huadong Pharmaceutical, Alp Pharm, Yancheng Youhua Pharmaceutical And Chemical Technology, Shandong Luxi Pharmaceutical, Jiangxi Nuclear Industry Reyphon Bio-Chemical, North China Pharmaceutical Huasheng, Ganzhou Ruizhi Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Polymyxin B Sulfate API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥99%
95%≤purity≤99%
Market segment by Application
Injection
Others
Major players covered
Xellia Pharmaceuticals Aps
Biotika As
Medisca
Hangzhou Zhongmei Huadong Pharmaceutical
Alp Pharm
Yancheng Youhua Pharmaceutical And Chemical Technology
Shandong Luxi Pharmaceutical
Jiangxi Nuclear Industry Reyphon Bio-Chemical
North China Pharmaceutical Huasheng
Ganzhou Ruizhi Pharmaceutical
ChemWerth
LGM Pharma
Rochem International
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polymyxin B Sulfate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Polymyxin B Sulfate API, with price, sales quantity, revenue, and global market share of Polymyxin B Sulfate API from 2020 to 2025.
Chapter 3, the Polymyxin B Sulfate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polymyxin B Sulfate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Polymyxin B Sulfate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Polymyxin B Sulfate API.
Chapter 14 and 15, to describe Polymyxin B Sulfate API sales channel, distributors, customers, research findings and conclusion.
Polymyxin B Sulfate Active Pharmaceutical Ingredient (API) refers to the active pharmaceutical ingredient used to produce polymyxin B sulfate preparations and is the core active substance in the preparation. Its chemical name is polymyxin B sulfate, which belongs to the polypeptide antibiotics. It is prepared by fermentation process or chemical synthesis and is ultimately used to prepare injections, powder injections and other dosage forms. Polymyxin B sulfate API is the basic substance for the production of drugs against multidrug-resistant Gram-negative bacteria, and its quality directly affects the safety and effectiveness of the preparation. Through strict process control and quality standards, its reliable application as a "last line of defense" antibiotic in clinical practice can be ensured.
The global increase in the infection rate of carbapenem-resistant Gram-negative bacteria (CRO), such as carbapenem-resistant Klebsiella pneumoniae (CRKP) and Pseudomonas aeruginosa (CRPA), has driven the demand for polymyxin B as a "last line of defense" antibiotic. The WHO lists polymyxins as core drugs for the treatment of multidrug-resistant bacterial infections, and the US IDSA guidelines also recommend their use in combination therapy. In addition, due to the abuse of antibiotics and differences in medical levels, the Asia-Pacific and Latin American regions have prominent problems with drug-resistant bacteria, making them the main regions for the growth of demand for polymyxin B sulfate API.
This report is a detailed and comprehensive analysis for global Polymyxin B Sulfate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Polymyxin B Sulfate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Polymyxin B Sulfate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Polymyxin B Sulfate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Polymyxin B Sulfate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Polymyxin B Sulfate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Polymyxin B Sulfate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xellia Pharmaceuticals Aps, Biotika As, Medisca, Hangzhou Zhongmei Huadong Pharmaceutical, Alp Pharm, Yancheng Youhua Pharmaceutical And Chemical Technology, Shandong Luxi Pharmaceutical, Jiangxi Nuclear Industry Reyphon Bio-Chemical, North China Pharmaceutical Huasheng, Ganzhou Ruizhi Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Polymyxin B Sulfate API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥99%
95%≤purity≤99%
Market segment by Application
Injection
Others
Major players covered
Xellia Pharmaceuticals Aps
Biotika As
Medisca
Hangzhou Zhongmei Huadong Pharmaceutical
Alp Pharm
Yancheng Youhua Pharmaceutical And Chemical Technology
Shandong Luxi Pharmaceutical
Jiangxi Nuclear Industry Reyphon Bio-Chemical
North China Pharmaceutical Huasheng
Ganzhou Ruizhi Pharmaceutical
ChemWerth
LGM Pharma
Rochem International
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polymyxin B Sulfate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Polymyxin B Sulfate API, with price, sales quantity, revenue, and global market share of Polymyxin B Sulfate API from 2020 to 2025.
Chapter 3, the Polymyxin B Sulfate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polymyxin B Sulfate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Polymyxin B Sulfate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Polymyxin B Sulfate API.
Chapter 14 and 15, to describe Polymyxin B Sulfate API sales channel, distributors, customers, research findings and conclusion.
Table of Contents
114 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Polymyxin B Sulfate API by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
